Nasdaq

Microinvasive Glaucoma Surgery with the OMNI® Surgical System is Associated with Diminished Diurnal IOP Fluctuations, a Significant, Independent Risk Factor for Glaucoma ...

12-Month OMNI data from the prospective, multicenter GEMINI clinical trial show statistically significant postoperative reductions in mean IOP and suppression of daily IOP fluctuations MENLO PARK, ...
Business Insider

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in ...

MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing ...
Nasdaq

Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment

Sight Sciences, Inc. has announced the launch of the OMNI® Edge Surgical System, an advanced technology designed for minimally invasive glaucoma surgery (MIGS). The new system will be showcased at the ...
AOL

UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...
Seeking Alpha

Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...
Healio

Omni system, cataract surgery combination reduces IOP at 24 months

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A study looked at real-world outcomes with Omni, Hydrus, ...
Seeking Alpha

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and ...
WRIC

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing ...